We report that the addition of an host paracaspase MALT1 inhibitor, MI-2, to HIV latently infected ACH-2, Jurkat E4, and J-LAT cells accelerated cell death in the presence of cell stimuli or the protein kinase C agonist, bryostatin 1. MI-2-mediated cell death correlated with the induction of the cellular RNase MCPIP1 and requires the presence of viral component(s). Altogether, the combination of MI-2 and bryostatin 1 displays selective killing of HIV latently infected CD4+ T cells.
BukrinskyMI, StanwickTL, DempseyMP, StevensonM: Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science, 1991; 254:423–427.
3.
McDougalJS, MawleA, CortSP, et al.: Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol, 1985; 135:3151–3162.
4.
GaneshL, BursteinE, Guha-NiyogiA, et al.: The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature, 2003; 426:853–857.
5.
DahabiehMS, BattivelliE, VerdinE: Understanding HIV latency: The road to an HIV cure. Annu Rev Med, 2015; 66:407–421.
6.
BullenCK, LairdGM, DurandCM, SilicianoJD, SilicianoRF: New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat Med, 2014; 20:425–429.
7.
CilloAR, SobolewskiMD, BoschRJ, et al.: Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A, 2014; 111:7078–7083.
8.
HoYC, ShanL, HosmaneNN, et al.: Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell, 2013; 155:540–551.
9.
ShanL, DengK, ShroffNS, et al.: Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity, 2012; 36:491–501.
10.
LiuS, QiuC, MiaoR, et al.: MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells. Proc Natl Acad Sci U S A, 2013; 110:19083–19088.
11.
JeltschKM, HuD, BrennerS, et al.: Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation. Nat Immunol, 2014; 15:1079–1089.
12.
UehataT, IwasakiH, VandenbonA, et al.: Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation. Cell, 2013; 153:1036–1049.
13.
Ruefli-BrasseAA, FrenchDM, DixitVM: Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science, 2003; 302:1581–1584.
14.
RulandJ, DuncanGS, WakehamA, MakTW: Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity, 2003; 19:749–758.
15.
RebeaudF, HailfingerS, Posevitz-FejfarA, et al.: The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol, 2008; 9:272–281.
16.
LiangJ, SaadY, LeiT, et al.: MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling. J Exp Med, 2010; 207:2959–2973.
17.
FontanL, YangC, KabaleeswaranV, et al.: MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell, 2012; 22:812–824.
18.
JordanA, BisgroveD, VerdinE: HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J, 2003; 22:1868–1877.
19.
PearsonR, KimYK, HokelloJ, et al.: Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol, 2008; 82:12291–12303.
20.
ClouseKA, PowellD, WashingtonI, et al.: Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol, 1989; 142:431–438.
21.
KinterAL, PoliG, MauryW, FolksTM, FauciAS: Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol, 1990; 64:4306–4312.
22.
QiD, HuangS, MiaoR, et al.: Monocyte chemotactic protein-induced protein 1 (MCPIP1) suppresses stress granule formation and determines apoptosis under stress. J Biol Chem, 2011; 286:41692–41700.
23.
XuJ, PengW, SunY, et al.: Structural study of MCPIP1 N-terminal conserved domain reveals a PIN-like RNase. Nucleic Acids Res, 2012; 40:6957–6965.
24.
NagelD, SprangerS, VincendeauM, et al.: Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. Cancer Cell, 2012; 22:825–837.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
